Association between cerebrospinal fluid tau and brain atrophy is not related to clinical severity in the Alzheimer's disease continuum

Psychiatry Research - Neuroimaging

Volumn 192, Issue 3, 2011, Pages 140-146

  Solé Padullés, Cristina ^a   Lladó, Albert ^a   Bartrés Faz, David ^b   Fortea, Juan ^a   Sánchez Valle, Raquel ^a   Bosch, Beatriz ^a   Antonell, Anna ^a   Molinuevo, José Luis ^a   Rami, Lorena ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Beta amyloid; CDR SB; Mild cognitive impairment; Regional brain atrophy; Subjective memory complaints; Tau proteins

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; TAU PROTEIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ASSESSMENT; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GRAY MATTER; HUMAN; LUMBAR PUNCTURE; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTERIOR CINGULATE; PRIORITY JOURNAL; RATING SCALE; VOXEL BASED MORPHOMETRY;

AGED; AGED, 80 AND OVER; AMYLOID BETA-PEPTIDES; ATROPHY; BRAIN; BRAIN MAPPING; COGNITION DISORDERS; DISEASE PROGRESSION; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEUROPSYCHOLOGICAL TESTS; PEPTIDE FRAGMENTS; PSYCHIATRIC STATUS RATING SCALES; QUESTIONNAIRES; SCHIZOPHRENIA; STATISTICS AS TOPIC; TAU PROTEINS;

EID: 79955964287     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2010.12.001     Document Type: Article

References (51)

1. Apostolova L.G., Hwang K.S., Andrawis J.P., Green A.E., Babakchanian S., Morra J.H., Cummings J.L., Toga A.W., Trojanowski J.Q., Shaw L.M., Jack C.R., Petersen R.C., Aisen P.S., Jagust W.J., Koeppe R.A., Mathis C.A., Weiner M.W., Thompson P.M. Alzheimer's Disease Neuroimaging Initiative. 3D PiB and CSF biomarker associations with hippocampal atrophy in ADNI subjects. Neurobiology of Aging 2010, 31:1284-1303.
2. Arriagada P.V., Marzloff K., Hyman B.T. Distribution of Alzheimer-type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's disease. Neurology 1992, 42:1681-1688.
3. Baleydier C., Mauguiere F. The duality of the cingulate gyrus in monkey. Neuroanatomical study and functional hypothesis. Brain 1980, 103:525-554.
4. Bennett D.A., Schneider J.A., Bienias J.L., Evans D.A., Wilson R.S. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions. Neurology 2005, 8:834-841.
5. Bosch B., Bartrés-Faz D., Rami L., Arenaza-Urquijo E.M., Fernández-Espejo D., Junqué C., Solé-Padullés C., Sánchez-Valle R., Bargalló N., Falcón C., Molinuevo J.L. Cognitive reserve modulates task-induced activations and deactivations in healthy elders, amnestic mild cognitive impairment and mild Alzheimer's disease. Cortex 2010, 46:451-461.
6. Bourgeat P., Chételat G., Villemagne V.L., Fripp J., Raniga P., Pike K., Acosta O., Szoeke C., Ourselin S., Ames D., Ellis K.A., Martins R.N., Masters C.L., Rowe C.C., Salvado O. Beta-amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia. Neurology 2010, 12:121-127.
7. Braak H., Alafuzoff I., Arzberger T., Kretzschmar H., Del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathologica 2006, 112:389-404.
8. Chételat G., Villemagne V.L., Bourgeat P., Pike K.E., Jones G., Ames D., Ellis K.A., Szoeke C., Martins R.N., O'Keefe G.J., Salvado O., Masters C.L., Rowe C.C. Australian Imaging Biomarkers and Lifestyle Research Group. Relationship between atrophy and beta-amyloid deposition in Alzheimer disease. Annals of Neurology 2010, 67:317-324.
9. Chételat G., Villemagne V.L., Pike K.E., Baron J.C., Bourgeat P., Jones G., Faux N.G., Ellis K.A., Salvado O., Szoeke C., Martins R.N., Ames D., Masters C.L., Rowe C.C., Australian Imaging Biomarkers and Lifestyle Study of Ageing (AIBL) Research Group Larger temporal volume in elderly with high versus low beta-amyloid deposition. Brain 2010, 133(11):3349-3358.
10. Colom R., Jung R.E., Haier R.J. Distributed brain sites for the g-factor intelligence. Neuroimage 2006, 31:1359-1365.
11. Edland S.D., Xu Y., Plevak M., O'Brien P., Tangalos E.G., Petersen R.C., Jack C.R. Total intracranial volume: normative values and lack of association with Alzheimer's disease. Neurology 2002, 23:272-274.
12. Fagan A.M., Head D., Shah A.R., Marcus D., Mintun M., Morris J.C., Holtzman D.M. Decreased cerebrospinal fluid Abeta(42) correlates with brain atrophy in cognitively normal elderly. Annals of Neurology 2009, 65:176-183.
13. Giannakopoulos P., Hof P.R., Giannakopoulos A.S., Herrmann F.R., Michel J.P., Bouras C. Regional distribution of neurofibrillary tangles and senile plaques in the cerebral cortex of very old patients. Archives of Neurology 1995, 52:1150-1159.
14. Grober E., Buschke H. Genuine memory deficits in dementia. Developmental Neuropsychology 1987, 3:13-36.
15. Hampel H., Bürger K., Teipel S.J., Bokde A.L., Zetterberg H., Blennow K. Core candidate neurochemical and imaging biomarkers of Alzheimer's disease. Alzheimer's & Dementia 2008, 4:38-48.
16. Hansson O., Zetterberg H., Buchhave P., Londos E., Blennow K., Minthon L. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurology 2006, 5:228-234.
17. Hardy J., Selkoe D.J. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002, 19:353-356.
18. Jack C.R., Lowe V.J., Senjem M.L., Weigand S.D., Kemp B.J., Shiung M.M., Knopman D.S., Boeve B.F., Klunk W.E., Mathis C.A., Petersen R.C. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. Brain 2008, 131:665-680.
19. Jack C.R., Knopman D.S., Jagust W.J., Shaw L.M., Aisen P.S., Weiner M.W., Petersen R.C., Trojanowski J.Q. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurology 2010, 9:119-128.
20. Josephs K.A., Whitwell J.L., Ahmed Z., Shiung M.M., Weigand S.D., Knopman D.S., Boeve B.F., Parisi J.E., Petersen R.C., Dickson D.W., Jack C.R. Beta-amyloid burden is not associated with rates of brain atrophy. Annals of Neurology 2008, 63:204-212.
21. Katzman R. Education and the prevalence of dementia and Alzheimer's disease. Neurology 1993, 43:13-20.
22. Knopman D.S., Parisi J.E., Salviati A., Floriach-Robert M., Boeve B.F., Ivnik R.J., Smith G.E., Dickson D.W., Johnson K.A., Petersen L.E., McDonald W.C., Braak H., Petersen R.C. Neuropathology of cognitively normal elderly. Journal of Neuropathology and Experimental Neurology 2003, 62:1087-1095.
23. Lehtovirta M., Laakso M.P., Frisoni G.B., Soininen H. How does the apolipoprotein E genotype modulate the brain in aging and in Alzheimer's disease? A review of neuroimaging studies. Neurobiology of Aging 2000, 21:293-300.
24. Lesné S., Koh M.T., Kotilinek L., Kayed R., Glabe C.G., Yang A., Gallagher M., Ashe K.H. A specific amyloid-beta protein assembly in the brain impairs memory. Nature 2006, 16:352-357.
25. Masters C.L., Cappai R., Barnham K.J., Villemagne V.L. Molecular mechanisms for Alzheimer's disease: implications for neuroimaging and therapeutics. Journal of Neurochemistry 2006, 97:1700-1725.
26. McDonald C.R., McEvoy L.K., Gharapetian L., Fennema-Notestine C., Hagler D.J., Holland D., Koyama A., Brewer J.B., Dale A.M. Alzheimer's Disease Neuroimaging Initiative. Regional rates of neocortical atrophy from normal aging to early Alzheimer disease. Neurology 2009, 11:457-465.
27. Mormino E.C., Kluth J.T., Madison C.M., Rabinovici G.D., Baker S.L., Miller B.L., Koeppe R.A., Mathis C.A., Weiner M.W., Jagust W.J. Alzheimer's Disease Neuroimaging Initiative. Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects. Brain 2009, 132:1310-1323.
28. Narr K.L., Woods R.P., Thompson P.M., Szeszko P., Robinson D., Dimtcheva T., Gurbani M., Toga A.W., Bilder R.M. Relationships between IQ and regional cortical gray matter thickness in healthy adults. Cerebral Cortex 2007, 17:2163-2171.
29. Nestor P.J., Fryer T.D., Smielewski P., Hodges J.R. Limbic hypometabolism in Alzheimer's disease and mild cognitive impairment. Annals of Neurology 2003, 54:343-351.
30. Pengas G., Hodges J.R., Watson P., Nestor P.J. Focal posterior cingulate atrophy in incipient Alzheimer's disease. Neurobiology of Aging 2010, 31:25-33.
31. Pfeffer R.I., Kurosaki T.T., Harrah C.H., Chance J.M., Filos S. Measurement of functional activities in older adults in the community. Journal of Gerontology 1982, 37:323-329.
32. Rami L., Gómez-Anson B., Sánchez-Valle R., Bosch B., Monte G.C., Lladó A., Molinuevo J.L. Longitudinal study of amnesic patients at high risk for Alzheimer's disease: clinical, neuropsychological and magnetic resonance spectroscopy features. Dementia and Geriatric Cognitive Disorders 2007, 24:402-410.
33. Rentz D.M., Locascio J.J., Becker J.A., Moran E.K., Eng E., Buckner R.L., Sperling R.A., Johnson K.A. Cognition, reserve, and amyloid deposition in normal aging. Annals of Neurology 2010, 67:353-364.
34. Satz P. Brain reserve capacity on symptom onset after brain injury: a formulation and review of evidence for threshold theory. Neuropsychology 1993, 7:273-295.
35. Scarmeas N., Albert S.M., Manly J.J., Stern Y. Education and rates of cognitive decline in incident Alzheimer's disease. Journal of Neurology Neurosurgery and Psychiatry 2006, 77:308-316.
36. Schönknecht P., Pantel J., Hartmann T., Werle E., Volkmann M., Essig M., Amann M., Zanabili N., Bardenheuer H., Hunt A., Schröder J. Cerebrospinal fluid tau levels in Alzheimer's disease are elevated when compared with vascular dementia but do not correlate with measures of cerebral atrophy. Psychiatry Research 2003, 120(3):231-238.
37. Schoonenboom N.S., van der Flier W.M., Blankenstein M.A., Bouwman F.H., Van Kamp G.J., Barkhof F., Scheltens P. CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease. Neurobiology of Aging 2008, 29:669-675.
38. Shaw L.M., Vanderstichele H., Knapik-Czajka M., Clark C.M., Aisen P.S., Petersen R.C., Blennow K., Soares H., Simon A., Lewczuk P., Dean R., Siemers E., Potter W., Lee V.M., Trojanowski J.Q. Alzheimer's Disease Neuroimaging Initiative. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects. Annals of Neurology 2009, 65:403-413.
39. Solé-Padullés C., Bartrés-Faz D., Junqué C., Vendrell P., Rami L., Clemente I.C., Bosch B., Villar A., Bargalló N., Jurado M.A., Barrios M., Molinuevo J.L. Brain structure and function related to cognitive reserve variables in normal aging, mild cognitive impairment and Alzheimer's disease. Neurobiology of Aging 2009, 30:1114-1124.
40. Stern Y. Cognitive reserve. Neuropsychologia 2009, 47:2015-2028.
41. Stern Y., Albert S., Tang M.X., Tsai W.Y. Rate of memory decline in AD is related to education and occupation: cognitive reserve?. Neurology 1999, 10:1942-1947.
42. Sunderland T., Wolozin B., Galasko D., Levy J., Dukoff R., Bahro M., Lasser R., Motter R., Lehtimäki T., Seubert P. Longitudinal stability of CSF tau levels in Alzheimer patients. Biological Psychiatry 1999, 15:750-755.
43. Sunderland T., Linker G., Mirza N., Putnam K.T., Friedman D.L., Kimmel L.H., Bergeson J., Manetti G.J., Zimmermann M., Tang B., Bartko J.J., Cohen R.M. Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. Journal of the American Medical Association 2003, 289:2094-2103.
44. Tapiola T., Alafuzoff I., Herukka S.K., Parkkinen L., Hartikainen P., Soininen H., Pirttilä T. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Archives of Neurology 2009, 66:382-389.
45. Thomann P.A., Kaiser E., Schönknecht P., Pantel J., Essig M., Schröder J. Association of total tau and phosphorylated tau 181 protein levels in cerebrospinal fluid with cerebral atrophy in mild cognitive impairment and Alzheimer disease. Journal of Psychiatry and Neuroscience 2009, 34:136-142.
46. Tisserand D.J., Bosma H., Van Boxtel M.P., Jolles J. Head size and cognitive ability in nondemented older adults are related. Neurology 2001, 10:969-971.
47. Vemuri P., Wiste H.J., Weigand S.D., Shaw L.M., Trojanowski J.Q., Weiner M.W., Knopman D.S., Petersen R.C., Jack C.R. Alzheimer's Disease Neuroimaging Initiative. MRI and CSF biomarkers in normal, MCI, and AD subjects: diagnostic discrimination and cognitive correlations. Neurology 2009, 28:287-293.
48. Vemuri P., Wiste H.J., Weigand S.D., Knopman D.S., Shaw L.M., Trojanowski J.Q., Aisen P.S., Weiner M., Petersen R.C., Jack C.R. Effect of apolipoprotein E on biomarkers of amyloid load and neuronal pathology in Alzheimer disease. Annals of Neurology 2010, 67:308-316.
49. Whitwell J.L., Josephs K.A., Murray M.E., Kantarci K., Przybelski S.A., Weigand S.D., Vemuri P., Senjem M.L., Parisi J.E., Knopman D.S., Boeve B.F., Petersen R.C., Dickson D.W., Jack C.R. MRI correlates of neurofibrillary tangle pathology at autopsy: a voxel-based morphometry study. Neurology 2008, 2:743-749.
50. Wilson R.S., Bennett D.A., Gilley D.W., Beckett L.A., Barnes L.L., Evans D.A. Premorbid reading activity and patterns of cognitive decline in Alzheimer disease. Archives of Neurology 2000, 57:1718-1723.
51. Winblad B., Palmer K., Kivipelto M., Jelic V., Fratiglioni L., Wahlund L.O., Nordberg A., Bäckman L., Albert M., Almkvist O., Arai H., Basun H., Blennow K., de Leon M., DeCarli C., Erkinjuntti T., Giacobini E., Graff C., Hardy J., Jack C., Jorm A., Ritchie K., van Duijn C., Visser P., Petersen R.C. Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. Journal of Internal Medicine 2004, 256:240-246.